Identification of high-risk groups in endometrial carcinoma stage I-II. A combination of DNA- and steroid receptor-measurements identifies early deaths from the disease.

Source:http://linkedlifedata.com/resource/pubmed/id/7645932

Download in:

View as

General Info

PMID
7645932